Soligenix, Inc. (SNGX)
0.91
-0.06
(-6.44%)
USD |
NASDAQ |
May 29, 16:00
0.8902
-0.02
(-2.18%)
After-Hours: 20:00
Soligenix EPS Diluted (Quarterly) : -0.2779 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NanoViricides, Inc. | -0.0921 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.825M |
| Total Expenses (Quarterly) | 2.825M |
| Enterprise Value | 7.791M |
| Earnings Yield | -216.9% |
| Normalized Earnings Yield | -216.89 |